China Pharma Holdings, Inc. (CHPI) Return on Investment ROI from the second quarter of 2012 to second quarter of 2011 and for the year 2012, average high and low, overall ranking from Jun 30 2012 to Jun 30 2011 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Pharma Holdings, Inc.  (CHPI)


China Pharma Holdings,'s ROI from its second quarter of 2012 to the second quarter of 2011 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is China Pharma Holdings,'s ROI in the second quarter of 2012?
China Pharma Holdings, Inc. achieved a return on average invested assets (ROI) of 15.49 % in its second quarter of 2012, which is below China Pharma Holdings,'s average return on investment, which stands at 31.52%.

ROI decreased relative to the period ending Mar 31 2012, due to the decline in net income.

Within the Healthcare sector 36 other companies had a higher return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2012 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter		 (Jun 30 2011)
II. Quarter
Y / Y Investment Change TTM 156.05 % 488.55 % - - -
Y / Y Net Income Change TTM -52.43 % 40.76 % 103.02 % 375.37 % -
Investment (TTM) in Millions 8 8 7 8 7
Return On Investment (TTM) 15.49 % 31.6 % 33.93 % 51.61 % 83.39 %
CHPI's Overall Ranking # # # # #
Seq. Investment Change TTM 2.69 % 11.09 % 37.83 % 62.85 % 136.04 %
Seq. Net Income Change TTM -49.66 % 3.47 % -9.4 % 0.8 % 48.96 %
Net Income (TTM) in Millions 1 2 2 3 3

CHPI Company Profile >> Back to CHPI Roi Comparisons >> See Annual CHPI Return On Investment



Return On Investment CHPI's Ranking
Within: No.
Industry # 13
Sector # 37
Overall #

Return On Investment Statistics
High Average Low
47.56 %
31.52 %
15.49 %
(Jun 30 2011)   (Jun 30 2012)







Financial Statements
China Pharma Holdings,'s II. Quarter Investments $ 8 Millions CHPI's Balance sheet
China Pharma Holdings,'s II. Quarter Income $ 0 Millions Quarterly CHPI's Income Statement
CHPI's Income by Division See CHPI's Income by Division


CHPI Annual Return On Investment (Dec 31 2010)
2011



Total Investments in Millions 5 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 2 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 33.8 % - - - -


Annual Roi Comment
In the fiscal year 2011 ROI improved to 33.8 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CHPI's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CHPI's Competitors
Subscribers only: Roi for China Pharma Holdings,'s Suppliers
Subscribers only: Return On Investment for CHPI's Customers

Other Ratios
CHPI's Roa CHPI's Inventory Turnover Ratio CHPI's Growth Rates CHPI's Dividend Statistics
CHPI's Profitability Ratios CHPI's Asset Turnover Ratio CHPI's Dividend Growth
CHPI's Roe CHPI's Valuation Ratios CHPI's Financial Strength Ratios CHPI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2012, within Healthcare Sector ROI
Veru Inc   41.86 %
Spectrum Pharmaceuticals Inc   40.72 %
Idexx Laboratories Inc  29.14 %
Neurocrine Biosciences Inc   24.55 %
Vertex Pharmaceuticals Inc  24.27 %
Varian Medical Systems Inc   23.70 %
United Therapeutics Corporation  22.39 %
Meridian Bioscience Inc   22.31 %
Exelixis Inc   21.40 %
Waters Corporation  19.97 %
Intuitive Surgical Inc   19.89 %
Medicines Co  19.04 %
Jazz Pharmaceuticals Plc  18.86 %
U S Physical Therapy Inc  18.79 %
Bio techne Corp  18.76 %
Nature s Sunshine Products inc   18.44 %
Mettler toledo International Inc   18.20 %
Gilead Sciences Inc   18.12 %
Celgene Corp  17.80 %
Biogen Inc   17.72 %
Bard C R Inc  16.71 %
Healthcare Services Group Inc   16.58 %
Hca Healthcare Inc   16.54 %
Baxter International Inc   16.53 %
3m Company  16.35 %
Option Care Health Inc   16.15 %
Eli Lilly And Company  16.05 %
Bristol myers Squibb Company  15.84 %
Zynex inc   15.59 %
China Pharma Holdings, Inc.  15.49 %

Date modified: 2026-09-02T20:25:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.